Structure of Clopidogrel
CAS No.: 113665-84-2
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Clopidogrel is an orally active platelet inhibitor targeting the P2Y12 receptor, used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Synonyms: Clopidogrelum
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 113665-84-2 |
Formula : | C16H16ClNO2S |
M.W : | 321.82 |
SMILES Code : | O=C(OC)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C=CS3)C2 |
Synonyms : |
Clopidogrelum
|
MDL No. : | MFCD05662337 |
InChI Key : | GKTWGGQPFAXNFI-HNNXBMFYSA-N |
Pubchem ID : | 60606 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
Concentration | Treated Time | Description | References |
HepG2 cells | 10 µM | 24 hours | To evaluate the effect of Clopidogrel on intracellular fat deposition in HepG2 cells, results showed that Clopidogrel had no significant effect on intracellular fat deposition. | PMC11013111 |
Bone marrow-derived macrophages (BMDMs) | 10 µM | 5 days | To investigate the effect of clopidogrel on TGF-β1-induced macrophage-to-myofibroblast transition (MMT). Results showed that clopidogrel significantly inhibited P2Y12 expression, MMT, and collagen-matrix production. | PMC9481993 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
C57BL/6J mice and IL-1R−/− mice | diet-induced obesity model | Oral | 5 mg/kg | single dose | To study the anti-platelet and anti-thrombotic effects of Clopidogrel in a diet-induced obesity model, it was found that wild-type DIO mice exhibited resistance to Clopidogrel, while IL-1R?/? DIO mice did not show resistance. | PMC7296442 |
Mice | Unilateral ureteral obstruction (UUO) model | Oral | 60 mg/kg/day | Once daily for 7 or 10 days | To investigate the therapeutic effect of clopidogrel on renal fibrosis in the UUO model. Results showed that clopidogrel significantly inhibited P2Y12 expression, TGF-β/Smad3 signaling, MMT, and renal fibrosis. | PMC9481993 |
C57BL/6 mice | High-fat diet-induced metabolic dysfunction-associated steatotic liver disease model | Oral | 35 mg/kg/day | Once daily for 15 weeks | To evaluate the effect of Clopidogrel on a metabolic dysfunction-associated steatotic liver disease model, results showed that Clopidogrel had no significant improvement on steatosis and inflammation. | PMC11013111 |
C57BL/6 mice | Photothrombotic stroke model | Intraperitoneal injection | 40 mg/kg | Once daily for 14 days | To investigate the impact of Clopidogrel on cognitive and motor function recovery in mice post-stroke. Results showed that Clopidogrel significantly impaired learning and memory recovery, reduced mouse survival rates and body weight, and increased vascular leakage and microglia numbers post-stroke. | PMC10380815 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03103685 | Dental Diseases|Antiplatelet A... More >>gents|Antiplatelet Drugs Less << | PHASE4 | UNKNOWN | 2018-12-30 | - |
NCT02054663 | Acute Coronary Syndrome | PHASE4 | COMPLETED | 2025-02-15 | University of Ottawa Heart Ins... More >>titute, Ottawa, Ontario, K1Y 4W7, Canada Less << |
NCT02707445 | Myocardial Ischemia|CLOPIDOGRE... More >>L, POOR METABOLISM of (Disorder) Less << | COMPLETED | 2025-02-16 | - | |
NCT00360386 | Ischemia | PHASE2 | COMPLETED | 2025-02-05 | - |
NCT02093299 | Stroke | TERMINATED | 2016-11-22 | Neurologisk afdeling, Roskilde... More >>, 4000, Denmark Less << | |
NCT02185534 | Bioequivalence, AUC, Cmax, Pha... More >>rmacokinetics Less << | PHASE1 | COMPLETED | 2025-10-14 | Research Site, Berlin, Germany |
NCT01012544 | Coronary Artery Stent Thrombos... More >>is Less << | PHASE4 | COMPLETED | 2025-12-09 | St Antonius Hospital, Nieuwege... More >>in, Utrecht, 3435CM, Netherlands Less << |
NCT01146301 | Carotid Stenosis | PHASE4 | COMPLETED | 2025-04-10 | St-Antonius Ziekenhuis, Nieuwe... More >>gein, Utrecht, 3435CM, Netherlands Less << |
NCT04501900 | Cardiovascular Diseases | PHASE4 | NOT_YET_RECRUITING | 2025-04-26 | - |
NCT02953405 | MCA - Middle Cerebral Artery D... More >>issection Less << | UNKNOWN | 2025-11-18 | SNUBH, Seoul, Korea, Republic ... More >>of Less << | |
NCT02391883 | Hip Fracture | COMPLETED | 2025-02-15 | - | |
NCT01159639 | Coronary Artery Disease|Aspiri... More >>n Resistance Less << | PHASE4 | COMPLETED | 2025-02-13 | Medical school Zagreb, Univers... More >>ity hospital center Zagreb, Zagreb, 10000, Croatia Less << |
NCT00781573 | Myocardial Infarction | COMPLETED | 2014-03-03 | Dallas Veterans Hospital, Dall... More >>as, Texas, 75216, United States|The Onassis cardiac Surgery Centre, Athens, Greece|Escorts Health Institute & Research Centre Ltd, New Delhi, India Less << | |
NCT06454045 | Coronary Artery Disease|Periph... More >>eral Arterial Disease Less << | ACTIVE_NOT_RECRUITING | 2028-05-13 | Heart Institute (InCor) / Univ... More >>ersity of S?o Paulo, S?o Paulo, Sao Paulo, 05403000, Brazil Less << | |
NCT03385538 | Ischemic Stroke | PHASE4 | COMPLETED | 2017-07-30 | Zealand University Hospital, d... More >>ept of neurology, Roskilde, 4000, Denmark Less << |
NCT02711410 | Platelet Aggregation Inhibitor... More >>s Less << | COMPLETED | 2025-10-15 | - | |
NCT00914368 | Coronary Artery Disease|Myocar... More >>dial Infarction|Stent Thrombosis|Heart Diseases|Acute Coronary Syndrome Less << | PHASE2 | COMPLETED | 2025-03-10 | Uppsala Clinical Research Cent... More >>er, Uppsala, 75185, Sweden Less << |
NCT01129063 | Healthy | PHASE1 | COMPLETED | 2025-05-09 | Sanofi-Aventis Administrative ... More >>Office, Paris, France Less << |
NCT00799045 | Migraine | PHASE4 | COMPLETED | 2025-12-16 | Hopital Laval, Quebec, G1V 4G5... More >>, Canada Less << |
NCT01113372 | Coronary Artery Disease | PHASE4 | COMPLETED | 2025-07-15 | Hospital Anchieta, Brasília, D... More >>F, Brazil|Hospital do Cora??o do Brasil, Brasília, Distrito Federal, Brazil|UNICOR, Linhares, ES, Brazil|Hospital Lifecenter, Belo Horizonte, MG, Brazil|Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil|Universidade Federal do Triangulo Mineiro, Uberaba, MG, Brazil|Instituto do Cora??o do Triangulo Mineiro, Uberlandia, MG, Brazil|Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|Centro Integrado de Medicina Intervencionista, Belém, PA, Brazil|Cardiocenter, Jo?o Pessoa, PB, Brazil|Hospital Agamenon Magalh?es, Recife, PE, Brazil|Procape, Recife, PE, Brazil|Funda??o Universitária de Cardiologia, Porto Alegre, RS, Brazil|Hospital M?e de Deus, Porto Alegre, RS, Brazil|Hospital S?o Lucas da PUC, Porto Alegre, RS, Brazil|Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital Santa Isabel, Blumenau, SC, Brazil|Instituto de Cardiologia de Santa Catarina, Florianópolis, SC, Brazil|Cardiologia Catanduva, Catanduva, SP, Brazil|Santa Casa de Limeira, Limeira, SP, Brazil|Santa Casa de Marília, Marília, SP, Brazil|INCORPI - Hosp. Fornecedores de Cana, Piracicaba, SP, Brazil|Santa Casa de S?o Carlos, S?o Carlos, SP, Brazil|Hospital Bandeirantes, S?o Paulo, SP, Brazil|Hospital Beneficência Portuguesa, S?o Paulo, SP, Brazil|Hospital Santa Marcelina, S?o Paulo, SP, Brazil|Instituto de Assistencia Médica ao Sevidor Público Estadual- IAMSPE, S?o Paulo, SP, Brazil|EMCOR Emergências do Cora??o, Piracicaba, S?o Paulo - SP, Brazil|Hospital das Clínicas de Ribeir?o Preto, Ribeir?o Preto, S?o Paulo - SP, Brazil|Funda??o Regional de Medicina de S?o José do Rio Preto, S?o José do Rio Preto, S?o Paulo, Brazil|INTERVECENTER Servi?os Cardiovasculares, Palmas, TO, Brazil|Instituto Dante Pazzanese de Cardiologia, S?o Paulo, 04012-180, Brazil Less << |
NCT00174759 | Arterial Occlusive Diseases | PHASE3 | COMPLETED | - | Sanofi-Aventis, North Ryde, Au... More >>stralia|Sanofi-Aventis, Vienna, Austria|Sanofi-Aventis, Brussels, Belgium|Sanofi-Aventis, Helsinki, Finland|Sanofi-Aventis, Paris, France|Sanofi-Aventis, Berlin, Germany|Sanofi-Aventis, Budapest, Hungary|Sanofi-Aventis, Milan, Italy|Sanofi-Aventis, Gouda, Netherlands|Sanofi-Aventis, Warsaw, Poland|Sanofi-Aventis, Barcelona, Spain|Sanofi-Aventis, Stockholm, Sweden|Sanofi-Aventis, Meyrin, Switzerland|Sanofi-Aventis, Guildford, United Kingdom Less << |
NCT01512485 | Healthy | PHASE1 | COMPLETED | 2025-10-06 | Anapharm, Sainte-Foy (Quebec),... More >> Canada Less << |
NCT05926271 | Acute Coronary Syndrome|CYP2C1... More >>9 Polymorphism Less << | PHASE2 | RECRUITING | 2027-01-15 | St. Antonius Hospital, Nieuweg... More >>ein, Utrecht, Netherlands Less << |
NCT01621763 | Healthy | PHASE1 | COMPLETED | 2025-09-08 | Lambda Therapeutic Research Lt... More >>d, Ahmedabad, Gujrat, India Less << |
NCT01032668 | Coronary Artery Disease | PHASE3 | COMPLETED | 2025-12-09 | Bursa Yüksek ?htisas E?itim ve... More >> Ara?t?rma Hastanesi, Bursa, 16320, Turkey Less << |
NCT05657041 | Coronary Artery Disease|Platel... More >>et Reactivity Less << | PHASE2|PHASE3 | RECRUITING | 2024-11-01 | StAntoniusH, Nieuwegein, Utrec... More >>ht, 3435CM, Netherlands|St. Antonius Hospital, Nieuwegein, Netherlands Less << |
NCT00513149 | Coronary Artery Disease | PHASE4 | UNKNOWN | 2025-07-11 | Division of Cardiology, Depart... More >>ment of Internal Medicine and Department of Medical Imaging, National Taiwan University Hospital, Taipei, 100, Taiwan Less << |
NCT00413608 | Healthy | PHASE1 | COMPLETED | 2025-01-09 | H?pital Européen Georges Pompi... More >>dou, Paris, 75015, France Less << |
NCT01325935 | Coronary Artery Disease | PHASE4 | COMPLETED | 2025-12-13 | Asahi General Hospital, Asahi ... More >>City, Chiba, Japan|Kimitsu Chuo Hospital, Kisarazu City, Chiba, Japan|Fukui Cardiovascular Center, Fukui City, Fukui, Japan|Fukuoka City Hospital, Fukuoka City, Fukuoka, Japan|Fukuoka City Medical Association Hospital, Fukuoka City, Fukuoka, Japan|Fukuoka Red Cross Hospital, Fukuoka City, Fukuoka, Japan|University of Occupational and Environmental Health, Kita-Kyushu City, Fukuoka, Japan|National Hospital Organization Fukuoka-Higashi Medical Center, Koga City, Fukuoka, Japan|Gifu Heart Center, Gifu City, Gifu, Japan|Fukuyama City Hospital, Fukuyama City, Hiroshima, Japan|Hiroshima Railway Hospital, Hiroshima City, Hiroshima, Japan|Tsuchiya General Hospital, Hiroshima City, Hiroshima, Japan|Engaru-Kosei General Hospital, Monbetsu-gun, Hokkaido, Japan|Hyogo Prefectural Amagasaki Hospital, Amagasaki City, Hyogo, Japan|Kansai Rosai Hospital, Cardiovascular Center, Amagasaki City, Hyogo, Japan|Kobe City Medical Center General Hospital, Kobe City, Hyogo, Japan|Shakaihoken Kobe Central Hospital, Kobe City, Hyogo, Japan|Miki City Hospital, Miki City, Hyogo, Japan|Hyogo College of Medicine, Nishinomiya City, Hyogo, Japan|Meiwa General Hospital, Nishinomiya City, Hyogo, Japan|Hyogo Prefectural Awaji Hospital, Sumoto City, Hyogo, Japan|Kanazawa University Hospital, Kanazawa City, Ishikawa, Japan|Kaisei General Hospital, Sakaide City, Kagawa, Japan|Kagoshima University Hospital, Kagoshima City, Kagoshima, Japan|Tenyoukai Central Hospital, Kagoshima City, Kagoshima, Japan|Ebina General Hospital, Ebina City, Kanagawa, Japan|Fujisawa City Hospital, Fujisawa City, Kanagawa, Japan|Kawasaki Municipal Tama Hospital, Kawasaki City, Kanagawa, Japan|St. Marianna University of Medicine, Toyoko Hospital, Kawasaki City, Kanagawa, Japan|St. Marianna University School of Medicine, Kawasaki City, Kanagawa, Japan|Synthesis Shinkawahashi Hospital, Kawasaki City, Kanagawa, Japan|Odawara Cardiovascular Hospital, Odawara City, Kanagawa, Japan|Kitazato University School of Medicine, Sagamihara City, Kanagawa, Japan|Sagamihara Kyodo Hospital, Sagamihara City, Kanagawa, Japan|Kanagawa Cardiovascular and Reppiratory Center, Yokohama City, Kanagawa, Japan|Saiseikai Yokohama Tobu Hospital, Yokohama City, Kanagawa, Japan|Showa University Fujigaoka Hospital, Yokohama City, Kanagawa, Japan|St. Marianna University of Medicine, Yokohama City West Hospital, Yokohama City, Kanagawa, Japan|Yokohama City University Hospital, Yokohama City, Kanagawa, Japan|Yokohama City UNiversity Medical Center, Yokohama City, Kanagawa, Japan|Kumamoto Chuo Hospital, Kumamoto City, Kumamoto, Japan|Kumamoto Red Cross Hospital, Kumamoto City, Kumamoto, Japan|National Hospital Organization Kumamoto Medical Center, Kumamoto City, Kumamoto, Japan|Saiseikai Kumamoto Hospital, Kumamoto City, Kumamoto, Japan|Sugimura Hospital, Kumamoto City, Kumamoto, Japan|Ijinkai Takeda General Hospital, Kyoto City, Kyoto, Japan|Koseikai Takeda Hospital, Kyoto City, Kyoto, Japan|Kyoto Second Red Cross Hospital, Kyoto City, Kyoto, Japan|Gakken The Holy City Medical Association Hospital, Sagara-gun, Kyoto, Japan|Uji Tokushukai Hospital, Uji City, Kyoto, Japan|Matsuzaka Central General Hospital, Matsuzaka City, Mie, Japan|Suzuka Central General Hospital, Suzuka City, Mie, Japan|Mie Heart Center, Taki-gun, Mie, Japan|Mie University Hospital, Tsu City, Mie, Japan|Nagasaki University Graduate School of Biomedical Science, Nagasaki City, Nagasaki, Japan|Kawasaki Medical School, Kurashiki City, Okayama, Japan|National Hospital Organization Okayama Medical Center, Okayama City, Okayama, Japan|The Sakakibara Heart Institute of Okayama, Okayama City, Okayama, Japan|Ohama Daiichi Hospital, Naha City, Okinawa, Japan|Nakagami Hospital, Okinawa City, Okinawa, Japan|Okinawa Nanbu Tokushukai Hospital, Shimajiri-gun, Okinawa, Japan|Urasoe General Hospital, Urasoe City, Okinawa, Japan|Kawachi General Hospital, Higashi Osaka City, Osaka, Japan|Kansai Medical University Hirakata Hospital, Hirakata City, Osaka, Japan|Kansai Medical University Takii Hospital, Moriguchi City, Osaka, Japan|Komatsu General Hospital, Neyagawa City, Osaka, Japan|Higashi-sumiyoshi Morimoto Hospital, Osaka City, Osaka, Japan|Nissay Hospital, Osaka City, Osaka, Japan|Osaka City General Hospital, Osaka City, Osaka, Japan|Osaka City University, Graduate School of Medicine, Osaka City, Osaka, Japan|Osaka Ekisaikai Hospital, Osaka City, Osaka, Japan|Osaka General Hospital of West Japan Railway Campany, Osaka City, Osaka, Japan|Osaka General Medical Center, Osaka City, Osaka, Japan|Osaka Gyoumeikan Hospital, Osaka City, Osaka, Japan|Osaka Police Hospital, Osaka City, Osaka, Japan|Sakurabashi Watanabe Hospital, Osaka City, Osaka, Japan|Bell Land General Hospital, Sakai City, Osaka, Japan|Mimihara General Hospital, Sakai City, Osaka, Japan|National Cerebral and Cardiovascular Center, Suita City, Osaka, Japan|Osaka University Graduate School of Medicine, Suita City, Osaka, Japan|Saiseikai Senri Hospital, Suita City, Osaka, Japan|Hokusetsu General Hospital, Takatsuki City, Osaka, Japan|Midorigaoka Hospital, Takatsuki City, Osaka, Japan|Department of Cardiovascular Medicine, Saga University, Saga City, Saga, Japan|Mashiko Hospital, Kawaguchi City, Saitama, Japan|Saitama Medical Center, Jichi Medical University, Saitama City, Saitama, Japan|Kusatsu Heart Center, Kusatsu City, Shiga, Japan|Shiga Medical Center for Adults, Moriyama City, Shiga, Japan|Omihachiman Community Medical Center, Omihachiman City, Shiga, Japan|Biwako Ohashi Hospital, Otsu City, Shiga, Japan|Hamamatsu Medical Center, Hamamatsu City, Shizuoka, Japan|Seirei Hamamatsu General Hospital, Hamamatsu City, Shizuoka, Japan|Juntendo University Shizuoka Hospital, Izunokuni City, Shizuoka, Japan|Tokushima Red Cross Hospital, Komatsujima City, Tokushima, Japan|Ayase Heart Hospital, Adachi-ku, Tokyo, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan|The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan|St. Luke's International Hospital, Chuo-ku, Tokyo, Japan|Sakakibara Heart Institute, Fuchu City, Tokyo, Japan|Tokyo Metroporitan Tama Medical Center, Fuchu City, Tokyo, Japan|Itabashi Chuo Medical Center, Itabashi-ku, Tokyo, Japan|Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan|Teikyo University Hospital, Itabashi-ku, Tokyo, Japan|Tokyo Metroporitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku, Tokyo, Japan|Toho University Medical Center Ohashi Hospital, Meguro-ku, Tokyo, Japan|The Cardiovascular Institute, Minato-ku, Tokyo, Japan|The Jikei University Hospital, Minato-ku, Tokyo, Japan|JR Tokyo General Hospital, Shibuya-ku, Tokyo, Japan|NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan|Tottri University, Yonago City, Tottri, Japan|Shuto General Hospital, Yanai City, Yamaguchi, Japan|Non-profit organization Associations for Establishiment of Evidence in Interventions, Minato-ku, Tokyo, 105-0013, Japan Less << |
NCT01621750 | Fasting | PHASE1 | COMPLETED | 2025-09-08 | Lambda Therapeutic Research Lt... More >>d, Ahmedabad, Gujrat, India Less << |
NCT00644657 | Coronary Artery Disease|Chest ... More >>Pain Less << | COMPLETED | 2025-09-08 | VA Medical Center, 1F187, Okla... More >>homa City, Oklahoma, 73104-5076, United States Less << | |
NCT01506713 | Fasting | PHASE1 | COMPLETED | 2025-09-06 | Anapharm, Sainte-Foy (Quebec),... More >> Canada Less << |
NCT01118793 | Coronary Artery Disease | COMPLETED | 2025-05-10 | Scripp Health, La Jolla, Calif... More >>ornia, 92037, United States Less << | |
NCT01955642 | Brain Ischemia|Ischemic Attack | COMPLETED | 2025-12-15 | CHU de Saint-Etienne, Saint-et... More >>ienne, 42000, France Less << | |
NCT00404053 | Acute Coronary Syndrome | PHASE4 | COMPLETED | 2025-11-06 | - |
NCT03667066 | Platelet Dysfunction | COMPLETED | 2018-06-01 | Eric Williams Medical Sciences... More >> Complex, Port Of Spain, North, 00000, Trinidad and Tobago Less << | |
NCT03329261 | Diabetes Mellitus, Type 2|NSTE... More >>MI - Non-ST Segment Elevation MI|Coronary Angioplasty Less << | PHASE4 | COMPLETED | 2019-12-20 | HMPIT, Ben Arous, Tunisia |
NCT06807788 | Takayasu Arteritis (TAK)|Vascu... More >>litis, Systemic Less << | ACTIVE_NOT_RECRUITING | 2027-10-14 | Heart Institute (InCor) / Univ... More >>ersity of S?o Paulo, S?o Paulo, S?o paulo, Brazil Less << | |
NCT03006835 | Coronary Heart Disease | PHASE4 | UNKNOWN | 2025-12-17 | - |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.11mL 0.62mL 0.31mL |
15.54mL 3.11mL 1.55mL |
31.07mL 6.21mL 3.11mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|